STANDARD BIOTOOLS INC. (LAB)
$0.65+$0.00 (+0.28%) Today
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 13 | 2,238,195 | |
| Tax withholding / forfeiture | 5 | 716,652 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
61 Form 4 filings on record, the earliest from Nov 21, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Sean Mackay - Officer | Tax withholding / forfeiture | Common Stock | 25,729 | $0.67 | $17K | |
 Hanjoon Alex Kim - Officer | Tax withholding / forfeiture | Common Stock | 28,195 | $0.67 | $19K | |
| Michael Egholm - Officer | Tax withholding / forfeiture | Common Stock | 97,627 | $0.67 | $66K | |
| Michael Egholm - Officer | Tax withholding / forfeiture | Common Stock | 362,625 | $0.87 | $315K | |
| Hanjoon Alex Kim - Officer | Tax withholding / forfeiture | Common Stock | 202,476 | $0.90 | $181K | |
| Thomas D. Carey | Grant or award | Common Stock | 99,116 | $0.00 | - | |
| Thomas D. Carey | Grant or award | Stock Option (Right to buy) | 263,884 | $0.00 | - | |
| Sean Mackay - Officer | Grant or award | Common Stock | 500,000 | $0.00 | - | |
| Frank Witney | Grant or award | Common Stock | 99,116 | $0.00 | - | |
| Frank Witney | Grant or award | Stock Option (Right to buy) | 175,923 | $0.00 | - | |
| Eli Casdin | Grant or award | Common Stock | 99,116 | $0.00 | - | |
| Eli Casdin | Grant or award | Stock Option (Right to buy) | 175,923 | $0.00 | - | |
 Troy Cox | Grant or award | Stock Option (Right to buy) | 175,923 | $0.00 | - | |
| Troy Cox | Grant or award | Common Stock | 99,116 | $0.00 | - | |
| Fenel M. Eloi | Grant or award | Common Stock | 99,116 | $0.00 | - | |
| Fenel M. Eloi | Grant or award | Stock Option (Right to buy) | 175,923 | $0.00 | - | |
| Kathy L. Hibbs | Grant or award | Stock Option (Right to buy) | 175,923 | $0.00 | - | |
| Kathy L. Hibbs | Grant or award | Common Stock | 99,116 | $0.00 | - | |
| Hanjoon Alex Kim - Officer | Tax withholding / forfeiture | Common Stock | 18,871 | $1.00 | $19K | |
| Sean Mackay - Officer | Tax withholding / forfeiture | Common Stock | 25,729 | $1.00 | $26K | |
| Michael Egholm - Officer | Tax withholding / forfeiture | Common Stock | 97,626 | $1.00 | $98K | |
| Michael Egholm - Officer | Option exercise | Common Stock | 196,513 | $0.00 | - | |
| Michael Egholm - Officer | Grant or award | Common Stock | 1,042,373 | $0.00 | - | |
| Michael Egholm - Officer | Tax withholding / forfeiture | Common Stock | 95,014 | $0.91 | $86K | |
| Michael Egholm - Officer | Grant or award | Stock Option (Right to buy) | 2,345,340 | $0.00 | - | |
| Michael Egholm - Officer | Option exercise | Restricted Stock Units | 196,513 | $0.00 | - | |
| Sean Mackay - Officer | Grant or award | Common Stock | 272,107 | $0.00 | - | |
| Sean Mackay - Officer | Grant or award | Stock Option (Right to buy) | 612,240 | $0.00 | - | |
| Hanjoon Alex Kim - Officer | Option exercise | Common Stock | 70,183 | $0.00 | - | |
| Hanjoon Alex Kim - Officer | Grant or award | Common Stock | 323,173 | $0.00 | - | |
| Hanjoon Alex Kim - Officer | Tax withholding / forfeiture | Common Stock | 21,301 | $0.91 | $19K | |
| Hanjoon Alex Kim - Officer | Grant or award | Stock Option (Right to buy) | 727,140 | $0.00 | - | |
| Hanjoon Alex Kim - Officer | Option exercise | Restricted Stock Units | 70,183 | $0.00 | - | |
| Eli Casdin | Grant or award | Common Stock | 52,991 | $1.17 | $62K | |
| Troy Cox | Grant or award | Common Stock | 57,264 | $1.17 | $67K | |
| Thomas D. Carey | Grant or award | Common Stock | 51,282 | $1.17 | $60K | |
| Michael Egholm - Officer | Tax withholding / forfeiture | Common Stock | 66,127 | $1.15 | $76K | |
| Sean Mackay - Officer | Tax withholding / forfeiture | Common Stock | 19,661 | $1.15 | $23K | |
| Hanjoon Alex Kim - Officer | Tax withholding / forfeiture | Common Stock | 12,740 | $1.15 | $15K | |
| Casdin Partners Master Fund, L.P. - Director | Open-market purchase | Common Stock, $0.001 par value per share | 125,000 | $1.42 | $178K | |
| Casdin Partners Master Fund, L.P. - Director | Open-market purchase | Common Stock, $0.001 par value per share | 75,000 | $1.44 | $108K | |
| Casdin Partners Master Fund, L.P. - Director | Open-market purchase | Common Stock, $0.001 par value per share | 150,000 | $1.45 | $217K | |
| Casdin Partners Master Fund, L.P. - Director | Open-market purchase | Common Stock, $0.001 par value per share | 150,000 | $1.43 | $215K | |
| Casdin Partners Master Fund, L.P. - Director | Open-market purchase | Common Stock, $0.001 par value per share | 7,550,000 | $1.30 | $9.84M | |
| Hanjoon Alex Kim - Officer | Tax withholding / forfeiture | Common Stock | 12,739 | $1.28 | $16K | |
| Sean Mackay - Officer | Tax withholding / forfeiture | Common Stock | 19,661 | $1.28 | $25K | |
| Michael Egholm - Officer | Tax withholding / forfeiture | Common Stock | 63,529 | $1.28 | $81K | |
| Casdin Partners Master Fund, L.P. - Director | Open-market purchase | Common Stock, $0.001 par value per share | 275,000 | $1.23 | $339K | |
| Casdin Partners Master Fund, L.P. - Director | Open-market purchase | Common Stock, $0.001 par value per share | 350,000 | $1.28 | $449K | |
| Casdin Partners Master Fund, L.P. - Director | Open-market purchase | Common Stock, $0.001 par value per share | 450,000 | $1.30 | $586K |
STANDARD BIOTOOLS INC. (LAB) had 12 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for LAB runs to 61 Form 4 filings, the earliest from 2024-11-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of LAB were filed in the last 90 days. 24 purchases are on record for this company.
No insider sales of LAB were filed in the last 90 days. 9 sales are on record for this company.
This page tracks LAB Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add LAB to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
